Affymax and Takeda Announce the Submission of a New Drug Application for Peginesatide for the Treatment of Anemia Associated with Chronic Renal Failure in Patients on Dialysis
Links shared publicly online about this topic.
- 252total visits
Affymax and Takeda Announce the Submission of a New Drug Application for Peginesatide for the Treatment of Anemia Associated with Chronic Renal Failure in Patients on Dialysis
Hematide (peginesatide) is a new drug in development for the treatment of anemia in chronic renal failure. Hematide information includes news, clinical trial results and side effects.
View full resource at drugs.com
Tags: Anemia, Kidney Health, Urinary System, Kidney Disease, Kidney Failure, Dialysis, Drug
Most Recently Shared on June 1, 2011 at 1:12 am By:
Affymax and Takeda Announce the Submission of a New Drug Application for Peginesatide for the Treatment of... http://bit.ly/jeqYlY #drug
Advertisement
